Skip to main content
    H

    Hyperion DeFi, Inc. (HYPD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.49
    -0.07 (-2.73%)

    Market Cap: $38.92M

    Last updated: Nov 06, 2026 at 4:29 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    58%(19/33)
    Avg Surprise
    -542.54%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$2.31
    Range$1.35 - $3.26
    2 analysts
    EPS Revisions
    1
    0
    7d
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.03+7783.3%
    60d ago$-0.04+6685.7%
    30d ago$-0.04+6685.7%
    7d ago$-0.33+798.5%
    Current$2.31
    Revenue Consensus
    $750000
    Range$700000 - $800000
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$4.35
    Range$2.95 - $5.75
    2 analysts
    Revenue Consensus
    $-300000
    Range$-300000 - $-300000
    2 analysts
    Last 12 of 34 reported quarters and 2 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$4.35$2.95 - $5.75--2--
    Sep 26EST
    		-$2.31$1.35 - $3.26--2
    2
    0
    30d
    		-
    Jun 26
    Reported Aug 12
    		$0.92N/A--58.93%Miss2
    No revisions (30d)
    		+136.8%
    Mar 26
    Reported May 14
    		$0.26N/A-N/ABeat--+116.0%
    Dec 25
    Reported Mar 26
    		$-6.29$-4.62--36.15%Miss--+61.7%
    Sep 25
    Reported Nov 13
    		$0.05N/A-+100.78%Beat--+100.6%
    Jun 25
    Reported Aug 13
    		$-2.50N/A-+65.31%Beat--+82.4%
    Mar 25
    Reported May 19
    		$-1.59N/A-+80.13%Beat--+89.6%
    Dec 24
    Reported Mar 26
    		$-16.44$-0.09--18166.67%Miss---9033.3%
    Sep 24
    Reported Nov 12
    		$-8.80$-8.00--10.00%Miss--+38.9%
    Jun 24
    Reported Aug 13
    		$-14.20$-16.00-+11.25%Beat---10.9%
    Mar 24
    Reported May 15
    		$-15.31$-13.87--10.38%Miss---10106.7%
    Dec 23
    Reported Mar 18
    		$-0.18$-0.17--5.88%Miss--+98.7%
    Sep 23
    Reported Nov 13
    		$-14.40$-15.20-+5.26%Beat--+14.3%

    Key Metrics

    Valuation
    P/E Ratio-0.49EV/EBITDA4.84x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin474.90%Operating Margin-758.00%
    ROE9.55%ROIC5.02%
    Financial Health
    Debt/Equity0.08xInterest Coverage7.04x
    Current Ratio2.34xQuick Ratio2.34x
    Trading Statistics
    Beta2.74Avg Volume269.52K
    52-Week High$6.3052-Week Low$2.34

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.97
    SMA 20$3.01
    SMA 50$3.37
    SMA 200$3.35
    EMA 10$2.90
    EMA 20$3.04
    EMA 50$3.20
    EMA 200$3.52

    MACD

    Line: -0.17Signal: -0.13Hist: -0.04

    ADX

    ADX: 17.9+DI: 21.2-DI: 34.4

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down100.0
    PSAR$3.63

    Bollinger Bands

    Upper Band$3.53
    Lower Band$2.50
    %B Position3429%(Upper)
    Band Width-0.01

    RSI (14-Day)

    Neutral
    36.0

    Momentum Oscillators

    Stoch %K16.7
    Stoch %D25.8
    Williams %R-90.6
    ROC (10d)-11.1%
    Momentum-0.31
    CCI (20d)-195.4
    MFI (14d)40.9

    Volatility Measures

    ATR (14d)$0.29(11.7%)
    StdDev (20d)0.26
    Hist Vol112.8%(High)

    Volume Flow

    VWAP$2.51
    OBV204.7M
    AD Line31.1M
    CMF (20d)-0.137

    Volume Metrics

    Avg Vol (20d)270.1K
    Vol Ratio1.6x(High)
    VWMA (20d)$3.04

    Pivot Points

    R3$3.37
    R2$3.20
    R1$2.88
    Pivot Point$2.71
    S1$2.39
    S2$2.22
    S3$1.90

    Advanced Oscillators

    TSI-15.39
    Ultimate Osc38.7
    KST-162.56

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$357,693$244,271$496,229$302,506$0$14,720$28,093$1,625$22,625$4,993$2,589$1,198
    Cost of Revenue$0$0$303,242$0$0$48$3.10M$132,522$490,361$203,027$2,589$13,416
    Gross Profit$357,693$244,271$192,987$302,506$0$14,672$-3,073,225$-130,897$-467,736$-198,034N/A$-12,218
    Operating Expenses$-30,650,049$-8,487,848$39.96M$-4,125,685$8.35M$3.05M$16.38M$7.20M$11.22M$10.07M$7.47M$6.51M
    R&D$58,491$286,764$188,954$373,855$674,578$673,043$1.96M$3.47M$4.60M$4.43M$4.06M$3.58M
    SG&A$3.92M$4.49M$4.53M$2.59M$7.68M$2.37M$3.21M$3.73M$3.76M$3.64M$3.40M$2.93M
    Operating Income$31.01M$8.73M$-39,765,277$4.43M$-8,353,282$-3,030,693$-19,451,130$-7,331,927$-11,688,344$-10,266,824$-7,466,554$-6,520,186
    Interest Income$206,764$244,167$138,878$43,858$21,933$35,349$23,220$44,999$64,866$120,939$198,668$208,901
    Interest Expense$233,760$225,869$314,422$223,080$528,410$581,499$529,663$602,109$674,001$678,658$680,623$679,222
    Income Before Tax$30.95M$8.84M$-39,765,565$6.63M$-8,690,919$-3,483,533$-19,954,780$-7,887,853$-11,053,699$-10,922,101$-7,967,137$-7,338,733
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$30.95M$8.84M$-39,765,565$6.63M$-8,690,919$-3,483,533$-19,954,780$-7,887,853$-11,053,699$-10,922,101$-7,967,137$-7,338,733
    EBITDA$31.03M$8.88M$-39,574,993$6.71M$-7,876,906$-2,659,411$-18,944,064$-7,116,775$-9,707,242$-9,932,447$-7,023,452$-6,365,787
    EBIT$30.98M$8.82M$-39,590,021$6.80M$-8,184,442$-2,937,383$-19,448,337$-7,330,743$-10,444,564$-10,364,382$-7,485,182$-6,868,412
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HYPD

    HYPD Valuation and Fair Value

    P/E
    -0.5x
    EV/EBITDA
    4.8x
    P/B
    0.3x
    See GNG's fair value

    HYPD Profitability: Margins, ROIC and FCF

    Gross margin
    78.4%
    Operating margin
    -758.0%
    Net margin
    474.9%
    ROIC
    5.0%
    ROE
    9.6%

    HYPD Competitors

    CompanyTicker
    CVRx IncCVRX
    Harvard Bioscience IncHBIO
    FibroGen IncFGEN
    eXoZymes, Inc.EXOZ
    Genenta Science SpA ADRGNTA
    Scynexis IncSCYX
    Dogwood Therapeutics, Inc.DWTX
    Elicio Therapeutics Inc.ELTX

    Sector: Healthcare

    HYPD Bull Case vs Bear Case

    Bull case

    • HYPD has a 474.9% net profit margin.
    • HYPD grew quarterly revenue 1560.0% year over year.

    HYPD Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    21.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $2.31
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 0 down

    HYPD Earnings Date

    HYPD reports Nov 12, 2026, before the open. The date is confirmed.

    HYPD Earnings Call

    The latest HYPD earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    HYPD ETF Holders

    GNG tracks 2 ETFs that hold HYPD. The largest weights:

    1. Invesco Alerian Galaxy Crypto Economy ETF (SATO), 1.80% of the fund
    2. Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
    Open the ETF Stock Exposure tool for HYPD

    Frequently Asked Questions About HYPD

    When does HYPD report earnings?

    Hyperion DeFi, Inc. (HYPD) is confirmed to report earnings on Nov 12, 2026.

    Does HYPD pay dividends?

    Hyperion DeFi, Inc. (HYPD) does not currently pay a regular dividend.

    What is HYPD's market cap?

    Hyperion DeFi, Inc. (HYPD) has a market capitalization of $38.92M with a current stock price of $2.49.

    Related stocks

    Sector: Healthcare

    All stocks starting with H

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In